RT Journal Article
SR Electronic
T1 Objective dystonia prediction with MRI after neonatal hypoxic-ischemic encephalopathy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.29.20116947
DO 10.1101/2020.05.29.20116947
A1 Keerthana Chintalapati
A1 Hanyang Miao
A1 Amit Mathur
A1 Jeff Neil
A1 Bhooma R. Aravamuthan
YR 2020
UL http://medrxiv.org/content/early/2020/05/29/2020.05.29.20116947.abstract
AB Aim To determine an objective and clinically-feasible method to predict dystonia in cerebral palsy (CP) using magnetic resonance imaging (MRI) following neonatal hypoxic-ischemic encephalopathy (HIE).Methods In this retrospective case-control study, we examined brain MRIs in neonates at age 4–5 days who underwent therapeutic hypothermia for HIE at a single tertiary care center. The lower average apparent diffusion coefficient (ADC) values between the left and right striatum and thalamus were determined using clinically-integrated software (IBM iConnect Access). Neonatal neurology, movement disorder, and cerebral palsy specialist notes were screened through age 5 years for motor abnormality documentation.Results In 50 subjects, ADC values significantly predicted dystonia in CP with receiver operator characteristic areas under the curve of 0.862 (p = 0.0004) in the striatum and 0.838 (p = 0.001) in the thalamus. Striatal ADC values less than 1.014×10−3 mm2/s provided 100% specificity and 70% sensitivity for dystonia. Thalamic ADC values less than 0.973×10−3 mm2/s provided 100% specificity and 80% sensitivity for dystonia.Interpretation In this small retrospective study, analysis of clinically-acquired MRIs predicted dystonia with high specificity following neonatal HIE. This could be a useful prognostication adjunct guiding when to establish appropriate vigilance for dystonia in CP.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding supporting this work is from the National Institutes of Neurological Disorders and Stroke (5K12NS098482-02).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This retrospective case-control study was approved by the Washington University School of Medicine Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe will make all data available to any qualified investigator upon request.